NO951640D0 - Antimicrobial 5-hydrazinoquinolone derivatives - Google Patents
Antimicrobial 5-hydrazinoquinolone derivativesInfo
- Publication number
- NO951640D0 NO951640D0 NO951640A NO951640A NO951640D0 NO 951640 D0 NO951640 D0 NO 951640D0 NO 951640 A NO951640 A NO 951640A NO 951640 A NO951640 A NO 951640A NO 951640 D0 NO951640 D0 NO 951640D0
- Authority
- NO
- Norway
- Prior art keywords
- hydrazinoquinolone
- antimicrobial
- derivatives
- hydrazinoquinolone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96896092A | 1992-10-30 | 1992-10-30 | |
| PCT/US1993/010091 WO1994010163A1 (en) | 1992-10-30 | 1993-10-22 | Antimicrobial 5-hydrazino-quinolone derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO951640D0 true NO951640D0 (en) | 1995-04-28 |
| NO951640L NO951640L (en) | 1995-06-30 |
Family
ID=25514997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO951640A NO951640L (en) | 1992-10-30 | 1995-04-28 | Antimicrobial 5-hydrazinoquinolone derivatives |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0666853A1 (en) |
| JP (1) | JPH08502750A (en) |
| KR (1) | KR950704301A (en) |
| CN (1) | CN1064357C (en) |
| AU (1) | AU687018B2 (en) |
| BR (1) | BR9307347A (en) |
| CA (1) | CA2148003A1 (en) |
| CZ (1) | CZ282581B6 (en) |
| EG (1) | EG20543A (en) |
| FI (1) | FI952049A7 (en) |
| HU (1) | HUT72072A (en) |
| IL (1) | IL107323A (en) |
| MX (1) | MX9306814A (en) |
| NO (1) | NO951640L (en) |
| NZ (1) | NZ257470A (en) |
| PL (1) | PL178094B1 (en) |
| RU (1) | RU2126000C1 (en) |
| SG (1) | SG59979A1 (en) |
| SK (1) | SK54795A3 (en) |
| WO (1) | WO1994010163A1 (en) |
| ZA (1) | ZA938089B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646163A (en) * | 1992-10-30 | 1997-07-08 | The Procter & Gamble Company | Quinolone 5-(N-heterosubstituted amino) antimicrobials |
| JPH10503521A (en) * | 1994-08-02 | 1998-03-31 | ザ、プロクター、エンド、ギャンブル、カンパニー | Method for producing quinolonyl lactam antimicrobial agent and novel intermediate compound |
| EP0775114B1 (en) * | 1994-08-02 | 2000-03-22 | The Procter & Gamble Company | Process for making antimicrobial compounds |
| DE69717970T2 (en) * | 1996-02-09 | 2003-04-30 | Toyama Chemical Co. Ltd., Tokio/Tokyo | CHINOLINE CARBONIC DERIVATIVES AND THEIR SALTS |
| RU2248199C1 (en) * | 2003-06-02 | 2005-03-20 | Открытое Акционерное Общество "Акционерное Курганское общество медицинских препаратов и изделий "Синтез" (ОАО "Синтез") | Eye drops and method for their obtaining |
| RU2265437C2 (en) * | 2003-07-02 | 2005-12-10 | Суханов Александр Владимирович | Method for treating gastric and duodenal diseases caused by helicobacter pylori |
| RU2245134C1 (en) * | 2003-09-02 | 2005-01-27 | Открытое акционерное общество "Красфарма" | Ofloxacine composition for injections |
| DK1666477T3 (en) | 2003-09-10 | 2013-07-29 | Kyorin Seiyaku Kk | 7- (4-TRISUBSTITUTED 3-CYCLOPROPYLAMINOMETHYL-1-PYRROLIDINYL) -QUINOLONCARBOXYLIC ACID DERIVATE |
| PL1901749T3 (en) * | 2005-05-18 | 2017-04-28 | Horizon Orphan Llc | Aerosolized fluoroquinolones and uses thereof |
| US8524735B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| EE05697B1 (en) | 2005-06-08 | 2014-02-17 | Janssen Pharmaceutica N.V. | Quinoline derivatives as antibacterial agents |
| EA010601B1 (en) * | 2005-06-09 | 2008-10-30 | Янссен Фармацевтика Н.В. | Quinoline derivatives as antibacterial agents |
| CN101020647B (en) * | 2007-02-14 | 2011-03-30 | 杭州师范学院 | A kind of synthetic method of β-cyclopropylaminoacrylic acid (ester) |
| JP5363350B2 (en) * | 2007-03-19 | 2013-12-11 | 武田薬品工業株式会社 | MAPK / ERK kinase inhibitor |
| PT3092901T (en) * | 2007-10-05 | 2020-05-21 | Senhwa Biosciences Inc | Quinolone analogs and methods related thereto |
| US8349829B2 (en) * | 2008-06-03 | 2013-01-08 | Actelion Pharmaceuticals Ltd. | [4-(1-amino-ethyl)-cyclohexyl]-methyl-amine and [6-(1-amino-ethyl)-tetrahydro-pyran-3-yl]-methyl-amine derivatives as antibacterials |
| CA2739897C (en) | 2008-10-07 | 2017-10-03 | Mpex Pharmaceuticals, Inc. | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
| US8629139B2 (en) | 2008-10-07 | 2014-01-14 | Mpex Pharmaceuticals, Inc. | Topical use of Levofloxacin for reducing lung inflammation |
| AR076222A1 (en) * | 2009-04-09 | 2011-05-26 | Actelion Pharmaceuticals Ltd | DERIVATIVES 2-HYDROXIETIL-1H-QUINOLIN-ONA AND ITS AZAISOTHERAL ANALOGS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| EP2473170B1 (en) | 2009-09-04 | 2019-06-19 | Horizon Orphan LLC | Use of aerosolized levofloxacin for treating cystic fibrosis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4668680A (en) * | 1985-12-12 | 1987-05-26 | Warner-Lambert Company | 5-amino-6,8-difluoroquinolones as antibacterial agents |
| JPH0228178A (en) * | 1988-04-23 | 1990-01-30 | Toyama Chem Co Ltd | Novel pyridonecarboxylic acid derivative and salt thereof |
| DE3906365A1 (en) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7- (1-PYRROLIDINYL) -3-CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES, METHOD AND SUBSTITUTED (OXA) DIAZABICYCLOOCTANES AND NONANESE AS INTERMEDIATE PRODUCTS, AND ANTIBACTERIAL AGENTS AND FOOD ADDITIVES CONTAINING THEM |
| PL166381B1 (en) * | 1989-08-16 | 1995-05-31 | Pfizer | Method for the production of new substituted 7-azabicycloquinolone carboxylic acids PL PL PL PL |
| DE69132256T2 (en) * | 1990-04-18 | 2001-01-25 | Procter & Gamble Pharmaceuticals, Inc. | ANTIMICROBIAL CHINOLONYL LACTAME |
| JPH06503565A (en) * | 1990-11-30 | 1994-04-21 | ワーナー−ランバート・コンパニー | Individual stereoisomers of 7-[3-(aminoalkyl)-1-pyrrolidinyl]-quinolone and naphthyridone as antibacterial agents |
-
1993
- 1993-01-30 EG EG68693A patent/EG20543A/en active
- 1993-10-19 IL IL10732393A patent/IL107323A/en not_active IP Right Cessation
- 1993-10-22 EP EP93924393A patent/EP0666853A1/en not_active Withdrawn
- 1993-10-22 JP JP6511167A patent/JPH08502750A/en active Pending
- 1993-10-22 RU RU95110762A patent/RU2126000C1/en active
- 1993-10-22 SG SG1996007851A patent/SG59979A1/en unknown
- 1993-10-22 NZ NZ257470A patent/NZ257470A/en unknown
- 1993-10-22 AU AU54097/94A patent/AU687018B2/en not_active Ceased
- 1993-10-22 CA CA002148003A patent/CA2148003A1/en not_active Abandoned
- 1993-10-22 WO PCT/US1993/010091 patent/WO1994010163A1/en not_active Ceased
- 1993-10-22 PL PL93308671A patent/PL178094B1/en unknown
- 1993-10-22 HU HU9501237A patent/HUT72072A/en unknown
- 1993-10-22 SK SK547-95A patent/SK54795A3/en unknown
- 1993-10-22 FI FI952049A patent/FI952049A7/en unknown
- 1993-10-22 CZ CZ951097A patent/CZ282581B6/en not_active IP Right Cessation
- 1993-10-22 KR KR1019950701690A patent/KR950704301A/en not_active Abandoned
- 1993-10-22 BR BR9307347A patent/BR9307347A/en not_active Application Discontinuation
- 1993-10-29 MX MX9306814A patent/MX9306814A/en not_active IP Right Cessation
- 1993-10-29 ZA ZA938089A patent/ZA938089B/en unknown
- 1993-10-30 CN CN93120224A patent/CN1064357C/en not_active Expired - Fee Related
-
1995
- 1995-04-28 NO NO951640A patent/NO951640L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2148003A1 (en) | 1994-05-11 |
| PL308671A1 (en) | 1995-08-21 |
| AU687018B2 (en) | 1998-02-19 |
| CZ282581B6 (en) | 1997-08-13 |
| RU95110762A (en) | 1997-01-10 |
| AU5409794A (en) | 1994-05-24 |
| IL107323A (en) | 2000-06-01 |
| SG59979A1 (en) | 1999-02-22 |
| HU9501237D0 (en) | 1995-06-28 |
| BR9307347A (en) | 1999-05-25 |
| FI952049L (en) | 1995-04-28 |
| HUT72072A (en) | 1996-03-28 |
| CZ109795A3 (en) | 1995-12-13 |
| MX9306814A (en) | 1994-07-29 |
| EP0666853A1 (en) | 1995-08-16 |
| JPH08502750A (en) | 1996-03-26 |
| KR950704301A (en) | 1995-11-17 |
| ZA938089B (en) | 1994-06-07 |
| PL178094B1 (en) | 2000-02-29 |
| WO1994010163A1 (en) | 1994-05-11 |
| CN1092773A (en) | 1994-09-28 |
| IL107323A0 (en) | 1994-01-25 |
| NO951640L (en) | 1995-06-30 |
| EG20543A (en) | 1999-07-31 |
| SK54795A3 (en) | 1995-12-06 |
| FI952049A0 (en) | 1995-04-28 |
| RU2126000C1 (en) | 1999-02-10 |
| NZ257470A (en) | 1997-08-22 |
| CN1064357C (en) | 2001-04-11 |
| FI952049A7 (en) | 1995-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI930208L (en) | QUINAZOLE DERIVATIVES | |
| FI935431A7 (en) | Kianzoline derivatives | |
| FI980341L (en) | 2-Oxyindole derivatives | |
| ATA75293A (en) | INDOLDER DERIVATIVES | |
| FI933037A7 (en) | THIAZOLOLYLPHENYL DERIVATIVES | |
| FI935805A7 (en) | Oxadiazine derivatives | |
| FI941423A7 (en) | 17beta-substituted 4-aza-5alpha-androstan-3-one derivatives | |
| DE69208877D1 (en) | CHINUCLIDINE DERIVATIVES | |
| NO922182L (en) | CRYSTALLINIC OXATATOLAN DERIVATIVES | |
| FI921262L (en) | 4-ARYLTHIAZOLE OR 4-ARYLIMIDAZOLE DERIVATIVES | |
| NO951640D0 (en) | Antimicrobial 5-hydrazinoquinolone derivatives | |
| NO920103D0 (en) | ANTIBACTERIAL AGENTS | |
| DE69330497D1 (en) | CHINAZOLIN DERIVATIVES | |
| FI20010214L (en) | Acylaminoindole derivatives | |
| KR950700911A (en) | Substituted 3-Pyrrolidinylthio-Carbapenems as Antimicrobial Agents | |
| DE59308714D1 (en) | CYCLOBUTANE-BENZENE DERIVATIVES | |
| FI20002460A7 (en) | 4-diphenylmethylpiperidine derivatives | |
| FI935228A7 (en) | 2-Alkoxy-2-imidazol-5-one fungicidal derivatives | |
| FI934082L (en) | Chitosan-based naerings- och laekemedelskompositioner Foer idisslare | |
| NO952288D0 (en) | Benzazepinon derivatives | |
| FI920111A7 (en) | Antibacterial agents | |
| DE69313890D1 (en) | 5-aminoflavone derivatives | |
| MX9206710A (en) | PIRIDINOL DERIVATIVES | |
| FI930367L (en) | PURIDINE DERIVATIVES | |
| FI950694L (en) | Antimicrobial composition |